Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 82.35

-4.5%

Jan 8 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mlkr who wrote (2986)	6/29/2010 4:15:22 PM
From: Jibacoa	of 3722

<<TEVA never goes down?>> It still isn't off from its near term DT coming from its March 23 H at $64.95 <g> But today it is among the ones staying on the green with volume of > 8.2M ahead of its ADV It seems to be forming a double bottom at the $51 level bigcharts.marketwatch.com TEVA has 4Qs of better revenues and earnings. The EE for 2010 & 2011 are around $4.55 & $5.10 vs. $3.27 in 2009 Phillip Frost, M.D., the Miami Dermatologist, is now TEVA's Chairman since March. tevapharm.com OPK and PBTH are some smaller companies where Dr. P.F. is one of the main investors.<g> TEVA's ACTAY is $69.73 It has been a good long term performer.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next